PETALING JAYA: Amway (Malaysia) Holdings Bhd’s net profit for the third quarter ended Sept 30, 2025, dropped to RM14.62mil from RM32.88mil in the previous corresponding period, while revenue fell to RM275.55mil from RM299.84mil a year earlier.
For the nine month period ended Sept 30, 2025, Amway’s net profit plunged to RM30.27mil from RM90.16mil in the previous corresponding period, while revenue declined to RM836.54mil from RM918.35mil a year earlier.
Amway offers a range of products including health supplements, personal care products, home tech and houseware, skincare and cosmetics, as well as household products.
In a filing with Bursa Malaysia, the company said revenue for the quarter and year-to-date ended Sept 30, 2025 were lower than the same period last year mainly due to lower demand towards health and wellness products and home appliances, partially offset by new cellular health product launch in the quarter.
The company noted that for the first nine months of 2025, it recorded a decline in revenue, reflecting the continued impact of weak consumer demand and a challenging economic environment.
“Despite these headwinds, the group remains committed to delivering shareholder value and upholding our position as a leading health and wellbeing company.
“The group will continue to focus on delivering holistic gut health solutions while adapting its business model to meet evolving consumer needs.”
Amway said profitability also declined in the same period, largely due to weaker sales and higher product costs.
“Given the prevailing uncertainties in the business environment, the group anticipates a decline in revenue and profit for the full year.”
Amway declared a third single tier interim dividend of 5.0 sen net per share in respect of the financial year ending Dec 31, 2025, to be paid on Dec 19, 2025.
